Summary of Significant Accounting Policies (Tables)

9 Months Ended

Mar. 31, 2014

Summary of Significant Accounting Policies

Schedule of the Company's net sales by medical indication

(In thousands)	For the Three Months Ended March 31,				For the Nine Months Ended March 31,
Medical Indication	2014		2013		2014		2013
Antibiotic	$	3,361	$	3,496	$	11,069	$	6,267
Cardiovascular	21,331		6,988		42,779		21,356
Gallstone	988		1,390		3,490		4,676
Glaucoma	4,538		1,627		7,474		4,608
Gout	3,383		1,776		7,445		2,907
Migraine	4,787		1,299		9,851		3,995
Obesity	915		1,074		2,890		3,488
Pain Management	8,407		4,980		20,418		14,752
Thyroid Deficiency	28,292		14,024		74,560		42,135
Other	3,995		2,368		13,176		6,696
Total	$	79,997	$	39,022	$	193,152	$	110,880

Summary of products which accounted for at least 10% of net sales

	For the Three Months Ended March 31,				For the Nine Months Ended March 31,
	2014		2013		2014		2013
Product 1	35	%	36	%	39	%	38	%
Product 2	24	%	6	%	19	%	8	%
Product 3	9	%	10	%	8	%	9	%
Product 4	2	%	12	%	3	%	11	%

Summary of customers which accounted for at least 10% of net sales

	For the Three Months Ended March 31,				For the Nine Months Ended March 31,
	2014		2013		2014		2013
Customer A	23	%	11	%	21	%	12	%
Customer B	14	%	16	%	15	%	16	%
Customer C	7	%	10	%	9	%	10	%